Back

Hypercoagulability and inflammation indicate increased risk for hypoattenuated leaflet thickening in patients with transcatheter aortic valve replacement

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Thromboembolic events and stroke in TAVI Aortic Valve Intervention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor David Hesselbarth

University Heart Center Freiburg-Bad Krozingen, Freiburg (Germany)

5 More presentations in this session

Presentation thumbnail
Risk factors for periprocedural stroke after transcatheter aortic valve implantation: a systematic review and meta-analysis
Doctor T. Theodoropoulou (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Porcelain aorta in TAVI: predictor of adverse outcomes or an overestimated risk factor?
Doctor M. Tagliafierro (New York, US)
Abstract Slides Video
Presentation thumbnail
Incidence and risk factors of stroke after transcatheter aortic valve implantation.
Doctor E. Picazo Feu (Badajoz, ES)
Abstract Slides Video
Presentation thumbnail
Atrial fibrillation in transfemoral transcatheter aortic valve implantation
Doctor A. Van Nieuwkerk (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
Sex differences in bleeding and ischemic outcomes after TAVI in patients on oral anticoagulants: a POPULAR PAUSE TAVI sub-analysis
Mr C. Venema (Groningen, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Thromboembolic events and stroke in TAVI

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Thrombelastography identifies patients at risk for major adverse cardiovascular events after transcatheter aortic valve implantation
thumbnail
Congress Presentation
Management of bioprosthetic valve thrombosis following transcatheter tricuspid valve replacement
thumbnail
Congress Presentation
Skirted prosthetic valves are associated with increased risk of subclinical leaflet thrombosis following transcatheter aortic valve replacement: a multicenter study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources